# How to Use CJC-1295: Dosage, Timing & Step-by-Step Protocol **By TelosRX Editorial Team** · 2026-08-28 **CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog studied for its ability to stimulate natural GH pulses. [TelosRX](https://telosrx.com) offers asynchronous provider-reviewed evaluations for compounded CJC-1295, subject to medical approval by a licensed provider. Compounded CJC-1295 is not FDA-approved.** Most peptide guides bury the practical stuff. This one starts there. Here's exactly how CJC-1295 is studied to be used — dosage ranges, timing, reconstitution, and what a compliant protocol looks like — with the science behind each step. Every step involving actual administration requires a provider-issued prescription and individualized dosing instructions from a licensed provider. These steps describe the general process for educational purposes. ## Step 1: Understand What CJC-1295 Is CJC-1295 is a modified GHRH peptide. It binds to GHRH receptors in the pituitary gland and prompts the release of growth hormone (GH) in a pulsatile pattern — mimicking how the body naturally releases GH. This is distinct from directly injecting synthetic GH. A 2006 study in [The Journal of Clinical Endocrinology & Metabolism (PubMed)](https://pubmed.ncbi.nlm.nih.gov/16822960/) confirmed that CJC-1295 produces sustained GH and IGF-1 elevation in healthy adults with a favorable safety profile at studied doses. There are two forms worth knowing: Form Half-Life Dosing Frequency Mechanism CJC-1295 without DAC (also called Mod GRF 1-29) ~30 minutes Multiple times daily (often 2–3x) Mimics a natural GHRH pulse CJC-1295 with DAC (Drug Affinity Complex) 6–8 days Once or twice weekly Drug Affinity Complex binds albumin for extended release Which form is appropriate for you is determined by your licensed provider based on your health goals and intake evaluation — not self-selection. ## Step 2: Confirm Your Eligibility Through a Provider Evaluation CJC-1295 is a compounded peptide, not an over-the-counter supplement. Obtaining it legally requires a provider-issued prescription following a medical evaluation. At TelosRX, this happens asynchronously — you complete a detailed health intake online, and a licensed provider reviews it without requiring a live appointment. The evaluation assesses your health history, current medications, and the appropriateness of peptide therapy for your situation. Approval is not guaranteed and is subject to the provider's medical judgment. Start your intake at [TelosRX](https://telosrx.com) — the process is asynchronous and fully online. ## Step 3: Understand Dosage Ranges (Educational Reference) Published research and compounding pharmacy protocols have studied a range of dosages. These are reference ranges from the research literature — your licensed provider will issue your specific dose. Form Studied Dose Range Frequency in Research CJC-1295 without DAC (Mod GRF 1-29) 100–200 mcg per injection 2–3x daily; often before sleep and around training CJC-1295 with DAC 1–2 mg per injection Once or twice per week These are educational reference figures. Individual dosing is determined by your prescribing provider based on your specific evaluation, not this table. Subject to medical approval and provider-issued prescription. ## Step 4: Timing — When to Inject Timing matters because CJC-1295 works by amplifying the body's natural GH pulses — and those pulses are inhibited when blood glucose is high or when somatostatin (GH's natural inhibitor) is elevated. - **Fasted state:** Injecting when fasted — either first thing in the morning or 2+ hours after a meal — appears to produce a better GH response in research models. - **Before sleep:** The largest natural GH pulse occurs in deep sleep. Injecting CJC-1295 without DAC close to sleep time may synchronize with this pulse. - **Post-workout:** A secondary injection post-exercise is used in some research protocols, as exercise also elevates natural GH secretion. Your provider's instructions take precedence over general timing guidelines. Subject to provider approval. ## Step 5: Reconstitution (If Applicable) Compounded CJC-1295 often arrives as a lyophilized (freeze-dried) powder. Reconstitution with bacteriostatic water is required before use. The general process: 1. Verify the vial label and expiration. Confirm the compounding pharmacy is licensed. 2. Use a sterile bacteriostatic water vial. Draw the prescribed volume using a sterile syringe. 3. Inject the bacteriostatic water slowly into the peptide vial, along the side (not directly onto the powder). 4. Gently swirl — do not shake — until the powder is fully dissolved. The solution should be clear. 5. Store the reconstituted vial refrigerated. Use within the compounding pharmacy's stated stability window. Your prescribing provider and compounding pharmacy will supply specific reconstitution instructions for your formulation. **Follow those instructions, not a general guide.** Subject to medical approval by a licensed provider. ## Step 6: Injection Technique CJC-1295 is administered subcutaneously — into the fatty tissue just under the skin, not into muscle. Common injection sites include the abdomen, thigh, and upper arm. - Rotate injection sites to prevent tissue changes at repeated sites. - Use a sterile insulin syringe (typically 27–31 gauge) for each injection. - Pinch the skin, insert at ~45–90 degrees, inject slowly, withdraw. - Dispose of needles immediately in an approved sharps container. Your provider will supply a patient instruction sheet as part of their prescription issuance. These steps are general educational context only. ## Step 7: Stacking with Ipamorelin (Common Research Context) CJC-1295 is frequently studied alongside Ipamorelin, a GHRP (growth hormone-releasing peptide) that works on a complementary receptor. Research published via [NCBI/PubMed](https://pubmed.ncbi.nlm.nih.gov/9475012/) characterizes GHRH+GHRP combination protocols and their synergistic effect on GH pulse amplitude in human subjects. Together, they produce a synergistic GH pulse in research models. This combination is the subject of our dedicated [CJC-1295 and Ipamorelin stack research article](https://www.telosrx.com/blogs/peptides/cjc-1295-ipamorelin-growth-hormone-stack-research). Whether stacking is appropriate for you is determined by your licensed provider — it's not a default recommendation. ## Step 8: What to Track and Watch For Research participants and clinical users typically monitor: - Sleep quality (improved deep sleep is a commonly reported observation) - Recovery rate from training or injury - Body composition changes over weeks to months - Side effects: water retention, tingling or numbness in extremities, temporary fatigue, headache in the early period If you experience significant adverse effects, contact your prescribing provider. Do not adjust your dose without provider guidance. For broader context on peptide research, see the [TelosRX Peptide Research blog](https://www.telosrx.com/blogs/peptides). ## Frequently Asked Questions ### What is CJC-1295 used for? CJC-1295 is a GHRH analog studied for its ability to stimulate pulsatile growth hormone release from the pituitary. Research applications include body composition, recovery, and sleep quality. It is not FDA-approved. Use requires a provider-issued prescription following a medical evaluation. ### What is the difference between CJC-1295 with DAC and without DAC? CJC-1295 without DAC (Mod GRF 1-29) has a short half-life (~30 minutes) and is used multiple times daily to mimic natural GH pulses. CJC-1295 with DAC binds albumin for an extended release, lasting 6–8 days, allowing once or twice weekly dosing. Your provider determines which form is appropriate for your protocol. ### How long does CJC-1295 take to produce effects? Research timelines vary. Some users report sleep quality improvements within the first few weeks. Body composition and recovery changes typically require consistent use over 8–12 weeks minimum. Individual responses vary significantly based on health status, dose, and lifestyle factors. ### Can CJC-1295 be stacked with Ipamorelin? Yes — CJC-1295 and Ipamorelin are frequently studied together because they work on complementary receptors to amplify GH pulses. Whether this combination is appropriate is determined by your licensed provider during the evaluation process. Both are compounded peptides that are not FDA-approved. ### Is CJC-1295 FDA-approved? No. CJC-1295 is not FDA-approved for any indication. It is a compounded peptide prepared under federal compounding regulations. Access requires a provider-issued prescription following a medical evaluation. TelosRX operates as an asynchronous telehealth platform for provider evaluations. ### What are the side effects of CJC-1295? Reported side effects include water retention, tingling or numbness in hands or feet, temporary fatigue, and headache — particularly in early use. These are generally transient. Report persistent or significant side effects to your prescribing provider promptly. ### How is CJC-1295 administered? CJC-1295 is injected subcutaneously — into the fatty layer just under the skin. Common sites include the abdomen, thigh, and upper arm. It requires reconstitution if supplied as lyophilized powder. Your prescribing provider will supply specific instructions. Subject to medical approval by a licensed provider. _TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service._ Start your private evaluation at [TelosRX](https://telosrx.com). **Tags:** CJC-1295, GHRH, growth hormone, how-to guide, peptides, protocol --- > Source: [Telos RX](https://www.telosrx.com/blogs/peptides/how-to-use-cjc-1295-dosage-protocol)